Impact of the hajj on pneumococcal transmission

Clinical Microbiology and Infection

Volumn 21, Issue 1, 2015, Pages 77.e11-77.e18

  Memish, Z A ^a,b   Assiri, A ^a   Almasri, M ^a   Alhakeem, R F ^a   Turkestani, A ^a   Al Rabeeah, A A ^a   Akkad, N ^a   Yezli, S ^a   Klugman, K P ^c   O'Brien, K L ^d   van der Linden, M ^e   Gessner, B D ^f  

^a MINISTRY OF HEALTH   (Saudi Arabia)

^b ALFAISAL UNIVERSITY   (Saudi Arabia)

^c EMORY UNIVERSITY   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^f Agence de Medecine Preventive   (France)

Author keywords

Antibiotic resistance; Carriage; Hajj; Pneumococcus; Streptococcus pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HAJJ; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSLIM; NASOPHARYNX; NONHUMAN; NOSE SMEAR; PNEUMOCOCCAL INFECTION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEROTYPE; VACCINATION; VERY ELDERLY; ADOLESCENT; CLASSIFICATION; CROWDING (AREA); DRUG EFFECTS; HETEROZYGOTE; ISLAM; MICROBIOLOGY; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; RISK FACTOR; SAUDI ARABIA; STREPTOCOCCUS PNEUMONIAE; TRANSMISSION; YOUNG ADULT;

STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARRIER STATE; CROSS-SECTIONAL STUDIES; CROWDING; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; ISLAM; MALE; MIDDLE AGED; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; RISK FACTORS; SAUDI ARABIA; STREPTOCOCCUS PNEUMONIAE; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84923004222     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2014.07.005     Document Type: Article

References (34)

1. World Health Organization Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly Epidemiol Rec 2007, 82:93-104.
2. Bogaert D., De Groot R., Hermans P.W. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004, 4:144-154.
3. US Centers for Disease Control and Prevention Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012, 61:816-819.
4. Borrow R., Heath P.T., Siegrist C.A. Use of pneumococcal polysaccharide vaccine in children: what is the evidence?. Curr Opin Infect Dis 2012, 25:292-303.
5. US Centers for Disease Control and Prevention Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005, 54:893-897.
6. Memish Z.A., Al-Rabeeah A.A. Public health management of mass gatherings: the Saudi Arabian experience with MERS-CoV. Bull WHO 2013, 91. 899-899A.
7. Gautret P., Parola P., Brouqui P. Relative risk for influenza like illness in French Hajj pilgrims compared to non-Hajj attending controls during the 2009 influenza pandemic. Travel Med Infect Dis 2013, 11:95-97.
8. Alzeer A.H. Respiratory tract infection during Hajj. Ann Thorac Med 2009, 4:50-53.
9. Madani T.A., Ghabrah T.M., Al-Hedaithy M.A., Alhazmi M.A., Alazraqi T.A., Albarrak A.M., et al. Causes of hospitalization of pilgrims in the Hajj season of the Islamic year 1423 (2003). Ann Saudi Med 2006, 26:346-351.
10. Mandourah Y., Al-Radi A., Ocheltree A.H., Ocheltree S.R., Fowler R.A. Clinical and temporal patterns of severe pneumonia causing critical illness during Hajj. BMC Infect Dis 2012, 12:117.
11. Ghaznawi H.I., Khalil M.H. Health hazards and risk factors in the 1406 H (1986 G) Hajj season. Saudi Med J 1988, 9:274-282.
12. El-Sheikh S.M., El-Assouli S.M., Mohammed K.A., Albar M. Bacteria and viruses that cause respiratory tract infections during the pilgrimage (Haj) season in Makkah, Saudi Arabia. Trop Med Int Health 1998, 3:205-209.
13. Alzeer A., Mashlah A., Fakim N., Al-Sugair N., Al-Hedaithy M., Al-Majed S., et al. Tuberculosis is the commonest cause of pneumonia requiring hospitalization during Hajj (pilgrimage to Makkah). JInfect 1998, 36:303-306.
14. Denamur E., Pautard J.C., Ducroix J.P., Masmoudi K., Eb F., Riou J.Y., et al. Meningococcal disease due to group A Neisseria meningitidis in contacts of Mecca pilgrims. Lancet 1987, 2:1211.
15. Moore P.S., Reeves M.W., Schwartz B., Gellin B.G., Broome C.V. Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet 1989, 2:260-263.
16. Jones D.M., Sutcliffe E.M. Group A meningococcal disease in England associated with the Haj. JInfect 1990, 21:21-25.
17. Qureshi H., Gessner B.D., Leboulleux D., Hasan H., Alam S.E., Moulton L.H. The incidence of vaccine preventable influenza-like illness and medication use among Pakistani pilgrims to the Haj in Saudi Arabia. Vaccine 2000, 18:2956-2962.
18. Mustafa A.N., Gessner B.D., Ismail R., Yusoff A.F., Abdullah N., Ishak I., et al. Acase-control study of influenza vaccine effectiveness among Malaysian pilgrims attending the Haj in Saudi Arabia. Int J Infect Dis 2003, 7:210-214.
19. Balkhy H.H., Memish Z.A., Bafaqeer S., Almuneef M.A. Influenza a common viral infection among Hajj pilgrims: time for routine surveillance and vaccination. JTravel Med 2004, 11:82-86.
20. Deris Z.Z., Hasan H., Sulaiman S.A., Wahab M.S., Naing N.N., Othman N.H. The prevalence of acute respiratory symptoms and role of protective measures among Malaysian hajj pilgrims. JTravel Med 2010, 17:82-88.
21. Khan N.A., Ishag A.M., Ahmad M.S., El-Sayed F.M., Bachal Z.A., Abbas T.G. Pattern of medical diseases and determinants of prognosis of hospitalization during 2005 Muslim pilgrimage Hajj in a tertiary care hospital. A prospective cohort study. Saudi Med J 2006, 27:1373-1380.
22. Al-Ghamdi S.M., Akbar H.O., Qari Y.A., Fathaldin O.A., Al-Rashed R.S. Pattern of admission to hospitals during muslim pilgrimage (Hajj). Saudi Med J 2003, 24:1073-1076.
23. Rashid H., Abdul Muttalif A.R., Mohamed Dahlan Z.B., Djauzi S., Iqbal Z., Karim H.M., et al. The potential for pneumococcal vaccination in Hajj pilgrims: expert opinion. Travel Med Infect Dis 2013, 11:288-294.
24. Benkouiten S., Gautret P., Belhouchat K., Drali T., Salez N., Memish Z.A., et al. Acquisition of Streptococcus pneumoniae carriage in pilgrims during the 2012 Hajj. Clin Infect Dis 2014, 58:e106-e109.
25. O'Brien K.L., Nohynek H. Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J 2003, 22:e1-11.
26. Neufeld F. Uber die agglutination der pneumokakken und uber die theorie der agglutination. Zeitschrift fur Hygiene und Infektionskrankheiten 1902, 34:54-72.
27. Enright M.C., Spratt B.G. Amultilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 1998, 144:3049-3060.
28. Mueller J.E., Yaro S., Ouedraogo M.S., Levina N., Njanpop-Lafourcade B.M., Tall H., et al. Pneumococci in the African meningitis belt: meningitis incidence and carriage prevalence in children and adults. PLoS One 2012, 7:e52464.
29. Parent dC I., Traore Y., Gessner B.D., Antignac A., Naccro B., Njanpop-Lafourcade B.M., et al. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clin Infect Dis 2005, 40:17-25.
30. Gessner B.D., Mueller J.E., Yaro S. African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults. BMC Infect Dis 2010, 10:22.
31. Tyrrell G.J., Lovgren M., Ibrahim Q., Garg S., Chui L., Boone T.J., et al. Epidemic of invasive pneumococcal disease, western Canada, 2005-2009. Emerg Infect Dis 2012, 18:733-740.
32. Balicer R.D., Zarka S., Levine H., Klement E., Sela T., Porat N., et al. Control of Streptococcus pneumoniae serotype 5 epidemic of severe pneumonia among young army recruits by mass antibiotic treatment and vaccination. Vaccine 2010, 28:5591-5596.
33. Ritchie N.D., Mitchell T.J., Evans T.J. What is different about serotype 1 pneumococci?. Future Microbiol 2012, 7:33-46.
34. Auranen K., Rinta-Kokko H., Goldblatt D., Nohynek H., O'Brien K.L., Satzke C., et al. Colonisation endpoints in Streptococcus pneumoniae vaccine trials. Vaccine 2013, 32:153-158.